Table 2.
Disease | Event | Component | Expression | In Vitro | In Vivo | Reference |
---|---|---|---|---|---|---|
Macrovascular | Coronary artery disease | Scl | ↑ | Endothelial dysfunction, alteration on proliferation, and migration of vascular smooth muscle cells | Atherosclerotic process, abnormal intima-media thickness, carotid plaques, aortic calcifications, and mortality | [59,60] |
Dkk-1 | ↑ | Regulates platelet-mediated inflammation and contributes to plaque de-escalation | Ischemic stroke and cardiovascular death | [61] | ||
↑ | Endothelial activation and release of inflammatory cytokines Endothelial–mesenchymal transition in aortic endothelial cells |
Onset and progression of atherosclerosis | [62] | |||
LRP6 | ↓ | LDL uptake was significantly lower in lymphoblastoid cells | Elevated plasma cholesterol and elevated plasma LDL, triglyceride, and fatty liver levels | [63] | ||
Wnt5a | ↑ | Induction of inflammatory gene expression GM-CSF, IL-1a, IL-3, IL-5, IL-6, IL-7, IL-8, CCL2, CCL8, and COX-2 in human aortic endothelial cells | Elevation of triglyceride levels, vascular insulin resistance, and endothelial dysfunction | [64] | ||
↑ | Macrophage activation | Increased recruitment of inflammatory cells and amplified inflammatory response | [65] | |||
Dkk-3 | ↓ | Increased intima-media thickness of the carotid artery | Delayed reendothelialization and aggravated neointima formation | [66] | ||
↑ | Induces differentiation of vascular progenitors and fibroblasts into smooth muscle cells | Larger and more vulnerable atherosclerotic lesions with more macrophages, fewer smooth muscle cells, and less extracellular matrix deposition | [67] | |||
TCF7L2 | ↓ | Loss of differentiation of vascular smooth muscle cells | Medial aortic hyperplasia | [68] | ||
Wnt2 | ↑ | Regulates smooth muscle cell migration | Triggers intima-media thickening | [69] | ||
LRP5 | ↓ | Activation of proinflammatory genes (interferon γ, IL15, IL18, and TNF ligand superfamily 13b). | Larger aortic atherosclerotic lesions | [70] | ||
Cerebrovascular disease | Scl | ↑ | Arterial calcification | Ischemic stroke caused by atherosclerotic stroke of large arteries or occlusion of small arteries | [71] | |
Dkk1 | ↑ | Biomarker for the presence of coronary atherosclerotic plaque | Carotid atherosclerosis, stable angina, and myocardial infarction Poor prognosis 1 year after ischemic stroke |
[72] | ||
miR-150-5p | ↑ | Regulates the Wnt signaling pathway and participates in cell proliferation and apoptosis by downregulating p53 | Inhibition of cell proliferation, colony formation, and tumor growth | [73] | ||
↓ | CD133− cells acquire a stem-cell-like phenotype | >Glioma | [74] | |||
β-catenin | ↑ | Key regulators for cadherin-mediated cell–cell adhesion |
Glioma Higher degree of malignancy of the tumor |
[74] | ||
Wnt1 | ↓ | Neuronal disappearance and increasing functional deficits | Oxidant stress and cerebral ischemia | [75] | ||
claudin-1 | ↓ | Neuronal damage | Increased permeability of the blood–brain barrier, petechial hemorrhage in the brain, neuronal injury, and central nervous system inflammation | [76] | ||
Claudin-3 | ↓ | Neuronal damage | Intracerebral petechial hemorrhages | [77] | ||
Wnt3a | ↑ | Alleviates neuronal apoptosis at the cellular and subcellular levels | Neuroprotection in traumatic brain injury, and ischemic stroke | [78] | ||
LRP6 | ↓ | Increased expression of inflammatory genes after middle artery occlusion | Risk of ischemic stroke, larger heart attack, and severe motor deficits | [79] | ||
Wnt5 | ↑ | Enhanced endothelial activation type 1 inflammatory mediator to promote endothelial activation type 2 | Brain aging Inflamed atheroma plaques |
[80] | ||
miRNA-148b | ↓ | Attenuates neural stem-cell proliferation and differentiation | Reduces ischemic injury and improves neurological function | [81] | ||
Peripheral arterial disease | Wnt5a | ↑ | Endothelial dysfunction | Increased risk of peripheral arterial occlusive disease, as well as metabolic and cardiovascular disorders | [82] | |
Sfrp5 | ↓ | Inhibition of cardiac fibroblast proliferation and migration Inflammation and myocardial injury |
ST-segment elevation myocardial infarction, metabolic syndrome, and increased risk of peripheral arterial occlusive disease | [82] | ||
CTHRC1 | ↑ | Synovial hyperplasia, contributes to the inflammatory microenvironment, and promotes pannus invasion through increased motility and invasion of synoviocytes | Increased risk of systemic lupus erythematosus, development of rheumatoid arthritis, and severity of the disease | [83] | ||
ALKBH5 | ↑ | Reduced proliferation and migration and decreased viability in hypoxic cardiac microvascular endothelial cells | Impaired hypoxic tube formation, but not the normoxic cardiac microvascular endothelial cells | [84] |
2 Dkk: Dickkopf; LRP: LDL receptor-related protein; LDL: low-density lipoprotein; Wnt: Wingless-Int; GM-CSF: granulocyte macrophage-colony stimulating factor; IL: interleukin; CCL: collagen crosslinking; COX: cyclooxygenase; TCF: transcription factor; TNF: tumor necrosis factor; Scl: sclerostin; CD: cluster of differentiation; Sfrp: secreted Frizzled-related proteins; CTHRC: collagen triple helix; ↑: upregulation; ↓: downregulation.